New York-based pharma giant Pfizer will finally be able to complete its $43 billion acquisition of Seagen, having addressed all of the concerns of antitrust reg 13 December 2023
British cell and gene therapy firm Oxford Biomedica has agreed terms with a subsidiary of Institut Mérieux for the acquisition of ABL Europe, for around $16 mil 4 December 2023
Life science investor Syncona has announced that its newly-established portfolio company has entered into an agreement to buy the remaining stake in Freeline Th 22 November 2023